Next Science (ASX:NXS) Beginning Cash Position : A$5.21 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Next Science Beginning Cash Position?

Next Science's Beginning Cash Position for the quarter that ended in Dec. 2023 was A$5.21 Mil.

Next Science's quarterly Beginning Cash Position declined from Dec. 2022 (A$16.40 Mil) to Jun. 2023 (A$7.56 Mil) and declined from Jun. 2023 (A$7.56 Mil) to Dec. 2023 (A$5.21 Mil).

Next Science's annual Beginning Cash Position declined from Dec. 2021 (A$21.44 Mil) to Dec. 2022 (A$10.92 Mil) and declined from Dec. 2022 (A$10.92 Mil) to Dec. 2023 (A$7.58 Mil).

Next Science Beginning Cash Position Historical Data

The historical data trend for Next Science's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Next Science Beginning Cash Position Chart

Next Science Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

10.47

22.46

21.44

10.92

7.58

Next Science Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial					18.45	10.43	16.40	7.56	5.21

Next Science Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Next Science Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Next Science's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Next Science (ASX:NXS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Next Science Ltd (ASX:NXS) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

NXSCF:USA

Address

821 Pacific Highway, Suite 1902, Level 19, Tower A, The Zenith Building, Chatswood, NSW, AUS, 2067

Website

https://www.nextscience.com

Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria. Its products include Bactisure, SURGX, XEPERIENCE and BLASTX. The company derives revenue from the U.S. and Australia, of which prime revenue is derived from the U.S.

Next Science (ASX:NXS) Headlines

No Headlines